|
 Studies
 Merz - our research for your health. Memantine produces symptomatic improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer s disease.
Studies: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Studies is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Studies now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Studies very serious, so that we can offer you the best drug for each treatment and therapy you need. Studies and Merz means research for your health. High-quality products and information about Studies can be found on our website. Visit us online and learn everything about Studies from one of Germany's leading health care companies. Our contribution to Studies: read here what we can do for you. Further links: Axura: Information for professionals.>>>
Memantine produces symptomatic improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer s disease.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . The excitatory effect of chronically released glutamate effects the degeneration of cortical and subcortical neurons, thus leading to the occurrence of dementia symptoms. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. A significant improvement in cognitive performance is seen during treatment with the NMDA antagonist, especially when only small vessels are affected. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Memantine produces symptomatic improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer s disease. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . This is clearly discernible behind the low background noise. This is clearly discernible behind the low background noise. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Merz is a leader in the field of Alzheimer research and developed the first drug for the treatment of moderate to severe Alzheimer s. Glutamate is the principal neurotransmitter in the brain. Other franchise covered by Merz are hepatology, metabolic diseases and dermatology. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . The 2 large studies have shown positive effects of memantine in mild to moderate cases of vascular dementia. However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms). Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity. Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . The excitatory effect of chronically released glutamate effects the degeneration of cortical and subcortical neurons, thus leading to the occurrence of dementia symptoms. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . Gedächtnis , Demenz . Merz , Multi Infarct Dementia . About 70 percent of all excitatory synapses in the central nervous system are stimulated by the neurotransmitter glutamate. Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . At the same time, Memantine reduces caregiver time by more than 50 hours a month. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Studies
|
